Literature DB >> 16580720

Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein.

A de Laurentiis1, M Caterino, S Orrù, M Ruoppolo, F Tuccillo, M Masullo, I Quinto, G Scala, P Pucci, C Palmieri, P Tassone, F Salvatore, S Venuta.   

Abstract

UN1 is a membrane glycoprotein that is expressed in immature human thymocytes, a subpopulation of peripheral T lymphocytes, the HPB acute lymphoblastic leukemia (ALL) T-cell line and fetal thymus. We previously reported the isolation of a monoclonal antibody (UN1 mAb) recognizing the UN1 protein that was classified as "unclustered" at the 5th and 6th International Workshop and Conference on Human Leukocyte Differentiation Antigens. UN1 was highly expressed in breast cancer tissues and was undetected in non-proliferative lesions and in normal breast tissues, indicating a role for UN1 in the development of a tumorigenic phenotype of breast cancer cells. In this study, we report a partial purification of the UN1 protein from HPB-ALL T cells by anion-exchange chromatography followed by immunoprecipitation with the UN1 mAb and MALDI-TOF MS analysis. This analysis should assist in identifying the amino acid sequence of UN1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580720     DOI: 10.1016/j.ijbiomac.2006.02.020

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice.

Authors:  Marijn A Gillissen; Greta de Jong; Martijn Kedde; Etsuko Yasuda; Sophie E Levie; Gemma Moiset; Paul J Hensbergen; Arjen Q Bakker; Koen Wagner; Jullien Villaudy; Pauline M van Helden; Hergen Spits; Mette D Hazenberg
Journal:  Blood Adv       Date:  2017-08-18

2.  Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.

Authors:  Annamaria de Laurentiis; Marco Gaspari; Camillo Palmieri; Cristina Falcone; Enrico Iaccino; Giuseppe Fiume; Ornella Massa; Mariorosario Masullo; Franca Maria Tuccillo; Laura Roveda; Ubaldo Prati; Olga Fierro; Immacolata Cozzolino; Giancarlo Troncone; Pierfrancesco Tassone; Giuseppe Scala; Ileana Quinto
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

3.  CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation.

Authors:  Antonio Pisano; Simona Ceglia; Camillo Palmieri; Eleonora Vecchio; Giuseppe Fiume; Annamaria de Laurentiis; Selena Mimmi; Cristina Falcone; Enrico Iaccino; Annarita Scialdone; Marilena Pontoriero; Francesca Fasanella Masci; Rosanna Valea; Shibu Krishnan; Marco Gaspari; Giovanni Cuda; Giuseppe Scala; Ileana Quinto
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

Review 4.  Aberrant glycosylation as biomarker for cancer: focus on CD43.

Authors:  Franca Maria Tuccillo; Annamaria de Laurentiis; Camillo Palmieri; Giuseppe Fiume; Patrizia Bonelli; Antonella Borrelli; Pierfrancesco Tassone; Iris Scala; Franco Maria Buonaguro; Ileana Quinto; Giuseppe Scala
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.